|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/47 | (2006.01) |
| (11) | Number of the document | 3140318 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15721694.6 |
| Date of filing the European patent application | 2015-05-07 | |
| (97) | Date of publication of the European application | 2017-03-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation | 2020-01-10 |
| (86) | Number | PCT/EP2015/060073 |
| Date | 2015-05-07 |
| (87) | Number | WO 2015/169901 |
| Date | 2015-11-12 |
| (30) | Number | Date | Country code |
| 201408135 | 2014-05-08 | GB |
| (72) |
KLOSTERMANN, Andreas, DE
STOCKHAUS, Jörg, DE
|
| (73) |
selectION Therapeutics GmbH,
Am Klopferspitz 19, 82152 Martinsried,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kv1.3 kalio kanalų antagonistai |
| Kv1.3 POTASSIUM CHANNEL ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-04-28 | 11 | 289.00 EUR |
| 2026-05-07 |